Aldehyde metabolite of 17.beta.-N-monosubstituted-carbamoyl-4-az

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

546 77, C07D22102

Patent

active

053807286

ABSTRACT:
17.beta.-N-monosubstituted-carbamoyl-4-aza-5.alpha.-androst-1-en-3-ones of the formula: ##STR1## wherein the dotted line can represent a double bond when present,

REFERENCES:
patent: 4760071 (1988-07-01), Rasmusson et al.
patent: 4845104 (1989-07-01), Carlin et al.
patent: 5324734 (1994-06-01), Gilbert
Stinson, Chem. & Eng. News, 29 Jun. 1992 pp. 7-8.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Aldehyde metabolite of 17.beta.-N-monosubstituted-carbamoyl-4-az does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Aldehyde metabolite of 17.beta.-N-monosubstituted-carbamoyl-4-az, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aldehyde metabolite of 17.beta.-N-monosubstituted-carbamoyl-4-az will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-850762

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.